Ken Takeshita, based in Bernards, NJ, US, is currently a Global Head of Research and Development at Daiichi Sankyo, Inc., bringing experience from previous roles at Kite Pharma, Sorrento Therapeutics, Inc. and Celgene. Ken Takeshita holds a AB @ Harvard University. With a robust skill set that includes Oncology, Biotechnology, Clinical Development, CRO, CRO Management and more, Ken Takeshita contributes valuable insights to the industry. Ken Takeshita has 1 email and 3 mobile phone numbers on RocketReach.